Surfactant treatment rate in very premature infants following change to less-invasive surfactant administration
Authors:
- 19 August 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 184 (9) , 1-9
Abstract
This study investigates whether implementation of a less-invasive surfactant administration (LISA) protocol in a level IIIb academic neonatal intensive care unit had an impact on the rate of infants treated with surfactant. This observational cohort study enrolled spontaneously breathing very premature infants, born < 33 weeks’ gestational age (GA), with worsening respiratory distress syndrome despite support with continuous positive airway pressure and in need of surfactant replacement therapy. Data were collected over two 3-year periods, preceding (P1, 2013–2015) and following (P2, 2019–2021) implementation of a LISA protocol. Nine hundred and six neonates were studied, 412 (45%) born in P1 and 494 (55%) in P2, with comparable GA, birthweight, and severity score (CRIB-II). Administration technique was mainly conventional at P1 (85%) and LISA at P2 (75%). Surfactant treatment rate decreased from 54% (224/412) at P1 to 47% (233/494) at P2 (p = 0.04), notably in infants born at 28–32 weeks’ GA (41 to 33%, OR [95% CI] 0.72 [0.53–0.99]). Among 23–32 weeks’ GA infants, need for invasive mechanical ventilation decreased from 56% (231/412) at P1 to 23% (113/494) at P2 (OR 0.23 [0.17–0.31], p < 0.001). Mortality and survival without severe morbidity were comparable. Conclusion: Implementation of a LISA protocol in our level IIIb NICU was associated with less surfactant use and lower exposure to invasive mechanical ventilation. What is Known: • Less-invasive surfactant administration (LISA) is a recommended mode to provide surfactant replacement therapy in premature infants with respiratory distress syndrome. • Few neonatal intensive care units (NICUs) have reported the impact of implementing this technique on the rate of infants treated with surfactant. What is New: • Implementation of a LISA protocol in our NICU was widely adopted by physicians, with application of this technique regardless of the degree of infant’s prematurity. • This change in practice was associated with less surfactant use and less exposure to invasive mechanical ventilation.Keywords
This publication has 36 references indexed in Scilit:
- Management of respiratory distress syndrome in moderate/late preterm neonates: A Delphi consensusAnales de Pediatría (English Edition), 2024
- Quantitative Lung Ultrasonography to Guide Surfactant Therapy in Neonates Born Late Preterm and LaterJAMA Network Open, 2024
- Lung ultrasound for the sick child: less harm and more information than a radiographEuropean Journal of Pediatrics, 2023
- Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress SyndromeJAMA, 2021
- Enhanced INSURE (ENSURE): an updated and standardised reference for surfactant administrationEuropean Journal of Pediatrics, 2021
- Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndromeCochrane Database of Systematic Reviews, 2021
- Premedication with ketamine or propofol for less invasive surfactant administration (LISA): observational study in the delivery roomEuropean Journal of Pediatrics, 2021
- 15‐Year trends in respiratory care of extremely preterm infants: Contributing factors and consequences on health and growth during hospitalizationPediatric Pulmonology, 2020
- Survival and Morbidity of Preterm Children Born at 22 Through 34 Weeks’ Gestation in France in 2011JAMA Pediatrics, 2015
- Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants2001